Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis.

Front Oncol · 2022 · PMC9166268 · PMID 35669434

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

≥10 ng/ml and BRAF -mutant melanoma showed a trend for a higher frequency of AEs as compared to individuals with BRAF wild-type melanomas.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.